Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
76 /100
CRITICAL RISK
Score updated Oct 13, 2026

AGEN — Agenus Inc. Dilution Risk Tracker

Track AGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AGEN — Get alerts when the score changes →

As of October 13, 2026, Agenus Inc. (AGEN) has a DilutionWatch DilutionScore of 76/100, rated CRITICAL dilution risk. Agenus Inc. has a market capitalization of $307.49M, 45.02M shares outstanding, 90 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
95
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 35%
💰 Capital Raise model 55%
• Critical: only 2.5 months cash remaining
🔄 Reverse Split model est. 15%
• Only 2 months cash — financial pressure
📉 Score Deterioration model 15%
• Score already CRITICAL (76/100) — events likely imminent
🔔 Track AGEN — Get forecast alerts →

Market Data

Market Cap$307.49M
Shares Outstanding45.02M
Float38.63M
Cash$33.38M
Debt$30.07M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore76/100DilutionWatch score record
Shares Outstanding45.02MVerified float table or market cache
Public Float38.63MVerified float table or market cache
Market Cap$307.49MMarket data cache
Cash Runway2.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 6.7% shares (2026Q1 vs prior)
90 institutional holders · 12.05M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.88M shares
#2 VANGUARD PORTFOLIO MANAGEMENT LLC 1.20M shares
#3 MORGAN STANLEY 1.13M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.82M
Days to Cover5.7
% of Float17.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-16
xbrl XBRL CONVERTIBLE 2024-03-14
4 INSIDER TRANSACTION 2026-04-06
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-24
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual AGEN Dilution Snapshot

Agenus Inc. (AGEN) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

AGEN's DilutionScore is currently 76/100 (Critical risk), with 4 score changes tracked over 89 days. The score improved from 65/100 (High risk).

Period Score Risk Level Duration
Sep 13 – Oct 13, 202676/100CRITICAL31 days
Aug 22 – Sep 12, 202665/100HIGH22 days
Aug 14 – Aug 21, 202661/100HIGH7 days
Jul 20 – Aug 13, 202652/100HIGH25 days
Jul 16 – Jul 19, 202650/100MEDIUM4 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

AGEN shares outstanding have increased 15.2% from 36.14M (Mar 2026) to 41.64M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 14, 202641.64M38.63M▲ 8.45%
Apr 17, 202638.40M35.62M▼ 0.04%
Apr 15, 202638.40M35.63M▼ 0.03%
Mar 21, 202638.40M35.64M▲ 1.01%
Mar 18, 202636.14M35.29M▲ 12.91%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track AGEN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment AGEN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking AGEN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AGEN
AGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.